Loading the player...


INFO:
From the 2022 San Antonio Breast Cancer Symposium (SABCS), Dr. Sparano, Mount Sinai, discusses the TailorX findings and the impact on treatment for some patients. Watch now.
2022 SABCS: Is There an Option to Omit Chemotherapy?